Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Catalyst Pharmaceutical Partners, Inc. (CPRX)  
$21.78 0.11 (0.5%) as of 4:30 Fri 6/27


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 103,650,000
Market Cap: 2.26(B)
Last Volume: 2,414,121 Avg Vol: 1,558,253
52 Week Range: $15.19 - $26.31
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drugs - Generic

Member Indexes:
    NASDAQ COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  1161
Guru Rank Value     : 0
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Catalyst Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing medicines for patients living with rare diseases. Co.'s primary product, Firdapse®, is used for the treatment of adult patients (ages 17 and above) with Lambert-Eaton, Myasthenic Syndrome, a rare autoimmune neuromuscular disorder characterized by muscle weakness of the limbs. Co. has developed its vigabatrin (CPP-109) as a generic version of Sabril®. Co. has an agreement with Endo International plc's subsidiary, Endo Ventures Limited, for the development and commercialization of generic Sabril® tablets through Endo's U.S. Generic Pharmaceuticals segment, Par Pharmaceutical.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 517,924 836,322 2,068,136 2,482,333
Total Sell Value $12,836,907 $19,874,831 $46,777,928 $52,893,646
Total People Sold 4 6 9 10
Total Sell Transactions 7 11 26 38
End Date 2025-03-30 2024-12-27 2024-06-28 2023-06-29

   
Records found: 389
  Page 1 of 16  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Sundaram Preethi Chief Strategy Officer   •       –      –    2025-06-11 4 S $26.42 $42,272 D/D (1,600) 41,081 14%     
   Sundaram Preethi Chief Strategy Officer   •       –      –    2025-06-10 4 S $26.41 $61,377 D/D (2,324) 42,681 17%     
   Mcenany Patrick J Chairman of Board of Directors   –       •      –    2025-06-09 4 S $26.11 $4,484,340 D/D (171,748) 4,281,702 16%     
   Mcenany Patrick J Chairman of Board of Directors   –       •      –    2025-06-06 4 S $25.95 $732,998 D/D (28,252) 4,453,450 16%     
   Daly Richard J President and CEO   •       •      –    2025-05-30 4 S $24.86 $1,740,200 D/D (70,000) 199,764 13%     
   Ingenito Gary Chief Med. & Reg. Officer   •       –      –    2025-05-14 4 S $23.63 $1,039,720 D/D (44,000) 68,873 7%     
   Ingenito Gary Chief Med. & Reg. Officer   •       –      –    2025-05-14 4 OE $4.64 $204,160 D/D 44,000 112,873     -
   Ingenito Gary Chief Med. & Reg. Officer   •       –      –    2025-05-13 4 S $23.68 $4,736,000 D/D (200,000) 68,873 8%     
   Ingenito Gary Chief Med. & Reg. Officer   •       –      –    2025-05-13 4 OE $3.42 $684,000 D/D 200,000 268,873     -
   Ingenito Gary Chief Med. & Reg. Officer   •       –      –    2025-03-06 4 S $21.67 $3,902,680 D/D (180,096) 68,873 -1%     
   Ingenito Gary Chief Med. & Reg. Officer   •       –      –    2025-03-06 4 OE $2.24 $403,415 D/D 180,096 248,969     -
   Ingenito Gary Chief Med. & Reg. Officer   •       –      –    2025-03-05 4 S $22.09 $991,929 D/D (44,904) 68,873 1%     
   Ingenito Gary Chief Med. & Reg. Officer   •       –      –    2025-03-05 4 OE $2.24 $100,585 D/D 44,904 113,777     -
   Elsbernd Brian Chief Compliance/Legal Officer   •       –      –    2025-03-03 4 S $22.93 $1,446,933 D/D (62,975) 188,564 2%     
   Elsbernd Brian Chief Compliance/Legal Officer   •       –      –    2025-03-03 4 OE $2.24 $140,056 D/D 62,525 241,819     -
   Del Carmen Jeffrey Chief Commercial Officer   •       –      –    2025-03-03 4 S $22.89 $696,382 D/D (30,423) 0 2%     
   Tierney David S Director   –       •      –    2025-02-14 4 OE $0.00 $0 D/D 4,000 355,620     -
   Del Carmen Jeffrey Chief Commercial Officer   •       –      –    2025-02-14 4 D $0.00 $0 D/D (3,125) 30,423     -
   Del Carmen Jeffrey Chief Commercial Officer   •       –      –    2025-02-14 4 OE $0.00 $0 D/D 10,667 33,548     -
   O'keeffe Charles B Director   –       •      –    2025-02-14 4 OE $0.00 $0 D/D 4,000 732,470     -
   Ingenito Gary Chief Med. & Reg. Officer   •       –      –    2025-02-14 4 D $0.00 $0 D/D (2,435) 68,873     -
   Ingenito Gary Chief Med. & Reg. Officer   •       –      –    2025-02-14 4 OE $0.00 $0 D/D 10,000 71,308     -
   Elsbernd Brian Chief Compliance/Legal Officer   •       –      –    2025-02-14 4 D $0.00 $0 D/D (2,353) 188,564     -
   Elsbernd Brian Chief Compliance/Legal Officer   •       –      –    2025-02-14 4 OE $0.00 $0 D/D 9,667 190,917     -
   Daly Richard J President and CEO   •       •      –    2025-02-14 4 D $0.00 $0 D/D (1,574) 269,764     -
  389 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 16
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us